\begin{table}[H]
\centering
\resizebox{\linewidth}{!}{
\begin{tabular}[t]{lrlrlr}
\toprule
\multicolumn{2}{c}{PBS} & \multicolumn{2}{c}{XP-EHH} & \multicolumn{2}{c}{iHS} \\
\cmidrule(l{3pt}r{3pt}){1-2} \cmidrule(l{3pt}r{3pt}){3-4} \cmidrule(l{3pt}r{3pt}){5-6}
Fenótipo & N & Fenótipo & N & Fenótipo & N\\
\midrule
\cellcolor{gray!6}{Body Mass Index} & \cellcolor{gray!6}{4} & \cellcolor{gray!6}{Body Height} & \cellcolor{gray!6}{4} & \cellcolor{gray!6}{Cholesterol, LDL} & \cellcolor{gray!6}{2}\\
Body Height & 3 & Caffeine consumption & 4 & Inborn genetic diseases & 2\\
\cellcolor{gray!6}{Alcoholic chronic pancreatitis} & \cellcolor{gray!6}{2} & \cellcolor{gray!6}{Diastolic blood pressure x smoking status (current vs non-current) interaction (2df test)} & \cellcolor{gray!6}{4} & \cellcolor{gray!6}{Lung adenocarcinoma} & \cellcolor{gray!6}{2}\\
Allergic disease (asthma, hay fever or eczema) & 2 & Diastolic blood pressure x smoking status (ever vs never) interaction (2df test) & 4 & squamous cell lung carcinoma & 2\\
\cellcolor{gray!6}{Blood pressure} & \cellcolor{gray!6}{2} & \cellcolor{gray!6}{Systolic blood pressure x smoking status (current vs non-current) interaction (2df test)} & \cellcolor{gray!6}{4} & \cellcolor{gray!6}{15q24 microdeletion syndrome} & \cellcolor{gray!6}{1}\\
Chronotype & 2 & Systolic blood pressure x smoking status (ever vs never) interaction (2df test) & 4 & Abnormality of brain morphology & 1\\
\cellcolor{gray!6}{Heart Rate} & \cellcolor{gray!6}{2} & \cellcolor{gray!6}{Systemic lupus erythematosus} & \cellcolor{gray!6}{3} & \cellcolor{gray!6}{Acute lymphoblastic leukemia} & \cellcolor{gray!6}{1}\\
Inborn genetic diseases & 2 & Alcoholic chronic pancreatitis & 2 & Acute myeloid leukemia & 1\\
\cellcolor{gray!6}{Malignant tumor of prostate} & \cellcolor{gray!6}{2} & \cellcolor{gray!6}{Autism spectrum disorder or schizophrenia} & \cellcolor{gray!6}{2} & \cellcolor{gray!6}{Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)} & \cellcolor{gray!6}{1}\\
Venous thromboembolism adjusted for sickle cell variant rs77121243-T & 2 & Blood trace element (Zn levels) & 2 & Ampulla of Vater Carcinoma & 1\\
\cellcolor{gray!6}{Waist circumference} & \cellcolor{gray!6}{2} & \cellcolor{gray!6}{Heart Rate} & \cellcolor{gray!6}{2} & \cellcolor{gray!6}{Apolipoprotein B levels} & \cellcolor{gray!6}{1}\\
ACETYL-CoA CARBOXYLASE DEFICIENCY & 1 & Heel bone mineral density & 2 & Atrial fibrillation & 1\\
\cellcolor{gray!6}{ARTHROGRYPOSIS, CLEFT PALATE, CRANIOSYNOSTOSIS, AND IMPAIRED INTELLECTUAL DEVELOPMENT} & \cellcolor{gray!6}{1} & \cellcolor{gray!6}{Hemoglobin A, Glycosylated} & \cellcolor{gray!6}{2} & \cellcolor{gray!6}{Autosomal recessive primary microcephaly} & \cellcolor{gray!6}{1}\\
Acetyl-CoA: carboxylase deficiency & 1 & Hemoglobin levels & 2 & B-cell acute lymphoblastic leukemia & 1\\
\cellcolor{gray!6}{Albumin-globulin ratio} & \cellcolor{gray!6}{1} & \cellcolor{gray!6}{Mean arterial pressure} & \cellcolor{gray!6}{2} & \cellcolor{gray!6}{Basal cell carcinoma} & \cellcolor{gray!6}{1}\\
Anorexia nervosa & 1 & Monocyte count & 2 & Blood protein levels & 1\\
\cellcolor{gray!6}{Aorta} & \cellcolor{gray!6}{1} & \cellcolor{gray!6}{Venous thromboembolism adjusted for sickle cell variant rs77121243-T} & \cellcolor{gray!6}{2} & \cellcolor{gray!6}{Breast carcinoma} & \cellcolor{gray!6}{1}\\
Arterial stiffness index & 1 & Adventurousness & 1 & Burkitts lymphoma & 1\\
\cellcolor{gray!6}{Asthma (childhood onset)} & \cellcolor{gray!6}{1} & \cellcolor{gray!6}{Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)} & \cellcolor{gray!6}{1} & \cellcolor{gray!6}{CELIAC DISEASE} & \cellcolor{gray!6}{1}\\
Autism spectrum disorder or schizophrenia & 1 & Adverse response to chemotherapy amenorrhea in breast cancer & 1 & Caffeine consumption & 1\\
\cellcolor{gray!6}{Autosomal dominant non-syndromic intellectual disability} & \cellcolor{gray!6}{1} & \cellcolor{gray!6}{Aorta} & \cellcolor{gray!6}{1} & \cellcolor{gray!6}{Carcinoma of esophagus} & \cellcolor{gray!6}{1}\\
Bitter non-alcoholic beverage consumption & 1 & Apolipoprotein A1 levels & 1 & Chin dimples & 1\\
\cellcolor{gray!6}{Blood Cells} & \cellcolor{gray!6}{1} & \cellcolor{gray!6}{Blood Cells} & \cellcolor{gray!6}{1} & \cellcolor{gray!6}{Chronic lymphocytic leukemia} & \cellcolor{gray!6}{1}\\
Blood protein levels & 1 & Blood pressure & 1 & Chronic myelogenous leukemia & 1\\
\cellcolor{gray!6}{Body fat distribution (arm fat ratio)} & \cellcolor{gray!6}{1} & \cellcolor{gray!6}{Blood urea nitrogen levels} & \cellcolor{gray!6}{1} & \cellcolor{gray!6}{Clear cell renal carcinoma} & \cellcolor{gray!6}{1}\\
Body fat distribution (leg fat ratio) & 1 & Body Mass Index & 1 & Clozapine-induced agranulocytosis & 1\\
\cellcolor{gray!6}{Body fat distribution (trunk fat ratio)} & \cellcolor{gray!6}{1} & \cellcolor{gray!6}{Bone properties (heel)} & \cellcolor{gray!6}{1} & \cellcolor{gray!6}{Coffee consumption} & \cellcolor{gray!6}{1}\\
Body fat percentage & 1 & Bone ultrasound measurement (broadband ultrasound attenuation) & 1 & Cutaneous T-cell lymphoma & 1\\
\cellcolor{gray!6}{Body mass index (joint analysis main effects and physical activity interaction)} & \cellcolor{gray!6}{1} & \cellcolor{gray!6}{Bone ultrasound measurement (velocity of sound)} & \cellcolor{gray!6}{1} & \cellcolor{gray!6}{Cutaneous melanoma} & \cellcolor{gray!6}{1}\\
Body mass index in physically active individuals & 1 & CELIAC DISEASE & 1 & Diastolic blood pressure & 1\\
\bottomrule
\end{tabular}}
\end{table}
